Focus

J&J vaccine

LATEST

Facts Matter
Facts Matter

EpochTV: 15M Contaminated Doses Cause US Government to Cancel Contract With Major Manufacturer

Facts Matter (Nov. 9): 15M Contaminated Doses Cause US Government to Cancel Contract With Major Manufacturer
|
Vaccines & Safety
Vaccines & Safety

J&J Vaccine Possibly Linked to 2 More Serious Health Conditions, EU Regulator Finds

J&J Vaccine Possibly Linked to 2 More Serious Health Conditions, EU Regulator Finds
|
Vaccines & Safety
Vaccines & Safety

NIH Director: J&J COVID-19 Vaccine Blood Clot Risk ‘Truly Rare’

NIH Director: J&J COVID-19 Vaccine Blood Clot Risk ‘Truly Rare’
|
Vaccines & Safety
Vaccines & Safety

FDA Examination Finds Substandard Conditions at Contractor’s Plant for J&J Vaccine Production

FDA Examination Finds Substandard Conditions at Contractor’s Plant for J&J Vaccine Production
|
Canada
Canada

Trudeau Says Johnson & Johnson Vaccine Faces Production Challenges

Trudeau Says Johnson & Johnson Vaccine Faces Production Challenges
|
Facts Matter
Facts Matter

EpochTV: 15M Contaminated Doses Cause US Government to Cancel Contract With Major Manufacturer

Facts Matter (Nov. 9): 15M Contaminated Doses Cause US Government to Cancel Contract With Major Manufacturer
|
Vaccines & Safety
Vaccines & Safety

J&J Vaccine Possibly Linked to 2 More Serious Health Conditions, EU Regulator Finds

J&J Vaccine Possibly Linked to 2 More Serious Health Conditions, EU Regulator Finds
|
Vaccines & Safety
Vaccines & Safety

NIH Director: J&J COVID-19 Vaccine Blood Clot Risk ‘Truly Rare’

NIH Director: J&J COVID-19 Vaccine Blood Clot Risk ‘Truly Rare’
|
Vaccines & Safety
Vaccines & Safety

FDA Examination Finds Substandard Conditions at Contractor’s Plant for J&J Vaccine Production

FDA Examination Finds Substandard Conditions at Contractor’s Plant for J&J Vaccine Production
|
Canada
Canada

Trudeau Says Johnson & Johnson Vaccine Faces Production Challenges

Trudeau Says Johnson & Johnson Vaccine Faces Production Challenges
|